These findings indicated that the overexpression of CCNB2 and ASPM accelerated the possibility of HCC deterioration and metastasis, suggesting a worse prognosis for HCC patients; hence, more aggressively integrated treatment and assessment were needed when these genes were found to be overexpressed. Here, CCNB2 is linked to hepatocellular carcinoma.